E-LIB Suche - Ergebnisse für: Calabrò, P. F.

1

Exploring the concept of eating dyscontrol in severely obes..:

Calderone, A. ; Mauri, M. ; Calabrò, P. F....
Clinical Obesity. 5 (2015) 1 - p. 22-30 , 2015

Link: https://doi.org/10.1111/..

2

Clinical outcomes, pharmacological treatment, and quality o..:

De Luca L ; Temporelli P. L ; Riccio C...
info:eu-repo/semantics/altIdentifier/pmid/30649303. , 2019

Link: http://hdl.handle.net/11..

3

PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS TREATED WIT..:

Sciahbasi, A ; Gargiulo, G ; Giacoppo, D...
European Heart Journal Supplements. 26 (2024) Supplement_2 - p. ii16-ii16 , 2024

Link: https://doi.org/10.1093/..

4

P109 INTRAVENOUS CANGRELOR INFUSION IN PATIENTS UNDERGOING ..:

Scalamera, R ; Benenati, S ; Gragnano, F...
European Heart Journal Supplements. 25 (2023) Supplement_D - p. D81-D81 , 2023

Link: https://doi.org/10.1093/..

5

P302 SIMULTANEOUS CORRECTION OF SEVERE LOW–FLOW LOW–GRADIEN..:

Scherillo, G ; Acerbo, V ; De Michele, G...
European Heart Journal Supplements. 25 (2023) Supplement_D - p. D158-D159 , 2023

Link: https://doi.org/10.1093/..

6

Efficacy and safety of inclisiran in real world practice: i..:

Basile, C ; Gargiulo, P ; Merlini, P A...
European Heart Journal. 44 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

7

Feasibility and implications of patient assessment in the f..:

Renon, F ; Liccardo, B ; D'andrea, A...
European Heart Journal: Acute Cardiovascular Care. 12 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

8

Efficacy, safety, adherence and persistence of PCSK9 inhibi..:

Gargiulo, P ; Basile, C ; Calabro', P...
European Heart Journal. 44 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

9

P298 TRANS–AXILLARY ACCESS AS AN ALTERNATIVE ROUTE IN TRANS..:

De Michele, G ; Moscarella, E ; Acerbo, V...
European Heart Journal Supplements. 25 (2023) Supplement_D - p. D157-D157 , 2023

Link: https://doi.org/10.1093/..

10

P297 INTRAVENOUS CANGRELOR INFUSION IN HIGH BLEEDING RISK P..:

Benenati, S ; Gragnano, F ; Scalamera, R...
European Heart Journal Supplements. 25 (2023) Supplement_D - p. D156-D157 , 2023

Link: https://doi.org/10.1093/..

11

P321 NEOVASC REDUCER IMPLANTATION AS A USEFUL THERAPEUTIC C..:

Acerbo, V ; De Michele, G ; Raucci, G...
European Heart Journal Supplements. 25 (2023) Supplement_D - p. D169-D169 , 2023

Link: https://doi.org/10.1093/..

12

C63 PREVALENCE AND CLINICAL SIGNIFICANCE OF RIGHT VENTRICUL..:

Palmiero, G ; Monda, E ; Verrillo, F...
European Heart Journal Supplements. 25 (2023) Supplement_D - p. D27-D27 , 2023

Link: https://doi.org/10.1093/..

13

C75 INTRAVENOUS CANGRELOR INFUSION IN ELDERLY PATIENTS UNDE..:

Scalamera, R ; Benenati, S ; Gragnano, F...
European Heart Journal Supplements. 25 (2023) Supplement_D - p. D31-D31 , 2023

Link: https://doi.org/10.1093/..

14

Impact of SGLT2-inhibitors on contrast-induced acute kidney..:

Paolisso, P ; Bergamaschi, L ; Cesaro, A...
European Heart Journal. 44 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

15

Everolimus-eluting bioresorabable scaffold system in the tr..:

Pighi, M ; Tomai, F ; Fezzi, S...
European Heart Journal. 43 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..